SEC Form 4 · accession 0001179110-15-003095
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — Chairman & CEO · Director
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 18, 2015 | F | 5,045 | $28.3824 | D | 313,674 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of common stock were withheld for payment of taxes in connection with the vesting of 12,000 shares of restricted stock from a previously reported grant.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $28.38 to a high of $28.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.